Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Role of IGF-I signaling in regulating osteoclastogenesis.

Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD.

J Bone Miner Res. 2006 Sep;21(9):1350-8.

PMID:
16939393
[PubMed - indexed for MEDLINE]
2.

Regulatory mechanisms of osteoblast and osteoclast differentiation.

Katagiri T, Takahashi N.

Oral Dis. 2002 May;8(3):147-59. Review.

PMID:
12108759
[PubMed - indexed for MEDLINE]
3.

A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.

Takahashi N, Udagawa N, Suda T.

Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. Review.

PMID:
10080918
[PubMed - indexed for MEDLINE]
4.

The molecular basis of osteoclast differentiation and activation.

Suda T, Kobayashi K, Jimi E, Udagawa N, Takahashi N.

Novartis Found Symp. 2001;232:235-47; discussion 247-50. Review.

PMID:
11277084
[PubMed - indexed for MEDLINE]
5.

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands.

Horowitz MC, Xi Y, Wilson K, Kacena MA.

Cytokine Growth Factor Rev. 2001 Mar;12(1):9-18. Review.

PMID:
11312114
[PubMed - indexed for MEDLINE]
6.

Current topics in pharmacological research on bone metabolism: osteoclast differentiation regulated by glycosphingolipids.

Fukumoto S, Iwamoto T, Sakai E, Yuasa K, Fukumoto E, Yamada A, Hasegawa T, Nonaka K, Kato Y.

J Pharmacol Sci. 2006 Mar;100(3):195-200. Epub 2006 Mar 14. Review.

PMID:
16538029
[PubMed - indexed for MEDLINE]
Free Article
7.

The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis.

Haynes DR, Crotti TN, Potter AE, Loric M, Atkins GJ, Howie DW, Findlay DM.

J Bone Joint Surg Br. 2001 Aug;83(6):902-11. Review.

PMID:
11521937
[PubMed - indexed for MEDLINE]
Free Article
8.

Mechanistic insight into osteoclast differentiation in osteoimmunology.

Takayanagi H.

J Mol Med (Berl). 2005 Mar;83(3):170-9. Epub 2005 Jan 26. Review.

PMID:
15776286
[PubMed - indexed for MEDLINE]
9.

Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics.

Zaidi M, Blair HC, Moonga BS, Abe E, Huang CL.

J Bone Miner Res. 2003 Apr;18(4):599-609. Review.

PMID:
12674320
[PubMed - indexed for MEDLINE]
10.

Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals.

Takahashi N, Maeda K, Ishihara A, Uehara S, Kobayashi Y.

Front Biosci (Landmark Ed). 2011 Jan 1;16:21-30. Review.

PMID:
21196156
[PubMed - indexed for MEDLINE]
11.

Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption.

Aubin JE, Bonnelye E.

Osteoporos Int. 2000;11(11):905-13. Review.

PMID:
11193242
[PubMed - indexed for MEDLINE]
12.

Insulin like growth factor-I: a critical mediator of the skeletal response to parathyroid hormone.

Bikle DD, Wang Y.

Curr Mol Pharmacol. 2012 Jun;5(2):135-42. Review.

PMID:
21787292
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[RANKL signaling and bone diseases. Quiescent osteoclast precursors and RANKL signaling].

Mizoguchi T.

Clin Calcium. 2011 Aug;21(8):1187-92. doi: CliCa110811871192. Review. Japanese.

PMID:
21814024
[PubMed - indexed for MEDLINE]
14.

[Regulatory mechanism of bone resorption: roles of bone remodeling-regulatory cytokines 'osteokines' in osteoclast differentiation and function].

Kobayashi Y, Takahashi N.

Nihon Rinsho. 2003 Feb;61(2):200-6. Review. Japanese.

PMID:
12638208
[PubMed - indexed for MEDLINE]
15.

[The OPG/RANKL/RANK system and bone resorptive disease].

Liu JZ, Ji ZL, Chen SM.

Sheng Wu Gong Cheng Xue Bao. 2003 Nov;19(6):655-60. Review. Chinese.

PMID:
15971575
[PubMed - indexed for MEDLINE]
16.

Mechanisms involved in bone resorption.

Udagawa N.

Biogerontology. 2002;3(1-2):79-83. Review.

PMID:
12014848
[PubMed - indexed for MEDLINE]
17.

Bone lysis and inflammation.

Haynes DR.

Inflamm Res. 2004 Nov;53(11):596-600. Review. Erratum in: Inflamm Res. 2011 Oct;60(10):997.

PMID:
15693607
[PubMed - indexed for MEDLINE]
18.

RANK/RANKL/OPG role in distraction osteogenesis.

Pérez-Sayáns M, Somoza-Martín JM, Barros-Angueira F, Rey JM, García-García A.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May;109(5):679-86. doi: 10.1016/j.tripleo.2009.10.042. Epub 2010 Feb 16. Review.

PMID:
20163972
[PubMed - indexed for MEDLINE]
19.

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ.

Endocr Rev. 1999 Jun;20(3):345-57. Review.

PMID:
10368775
[PubMed - indexed for MEDLINE]
20.

[Osteoclastogenesis and bone resorption].

Nakamura M, Nakamichi Y, Nakamura H, Udagawa N.

Nihon Rinsho. 2009 May;67(5):889-96. Review. Japanese.

PMID:
19432105
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk